NasdaqGS - Nasdaq Real Time Price • USD
IDEXX Laboratories, Inc. (IDXX)
At close: April 19 at 4:00 PM EDT
After hours: April 19 at 4:20 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 8 | 8 | 12 | 12 |
| Avg. Estimate | 2.67 | 3 | 11.13 | 12.7 |
| Low Estimate | 2.6 | 2.96 | 10.92 | 11.72 |
| High Estimate | 2.75 | 3.07 | 11.31 | 13.2 |
| Year Ago EPS | 2.55 | 2.67 | 10.06 | 11.13 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 12 | 12 |
| Avg. Estimate | 967.21M | 1.03B | 3.99B | 4.39B |
| Low Estimate | 964.63M | 1.02B | 3.94B | 4.3B |
| High Estimate | 972M | 1.04B | 4.03B | 4.5B |
| Year Ago Sales | 892.47M | -- | 3.66B | 3.99B |
| Sales Growth (year/est) | 8.40% | -- | 9.00% | 10.00% |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | 2.42 | 2.47 | 2.37 | 2.12 |
| EPS Actual | 2.55 | 2.67 | 2.53 | 2.32 |
| Difference | 0.13 | 0.2 | 0.16 | 0.2 |
| Surprise % | 5.40% | 8.10% | 6.80% | 9.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 2.67 | 3 | 11.13 | 12.7 |
| 7 Days Ago | 2.67 | 3 | 11.13 | 12.7 |
| 30 Days Ago | 2.67 | 3 | 11.14 | 12.71 |
| 60 Days Ago | 2.68 | 2.98 | 11.14 | 12.72 |
| 90 Days Ago | 2.75 | 2.97 | 10.97 | 12.52 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | IDXX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 4.70% | -- | -- | 1.60% |
| Next Qtr. | 12.40% | -- | -- | 10.50% |
| Current Year | 10.60% | -- | -- | 5.20% |
| Next Year | 14.10% | -- | -- | 13.30% |
| Next 5 Years (per annum) | 12.00% | -- | -- | 11.22% |
| Past 5 Years (per annum) | 18.36% | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Upgrades & Downgrades
| Maintains | JP Morgan: Overweight to Overweight | 2/6/2024 |
| Maintains | Barclays: Overweight to Overweight | 2/6/2024 |
| Downgrade | Piper Sandler: Overweight to Neutral | 1/30/2024 |
| Maintains | Goldman Sachs: Buy to Buy | 1/17/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 11/6/2023 |
| Maintains | Goldman Sachs: Buy to Buy | 11/3/2023 |
Related Tickers
MTD Mettler-Toledo International Inc.
1,188.54
-0.34%
MEDP Medpace Holdings, Inc.
372.00
-0.62%
WAT Waters Corporation
296.10
+0.64%
DHR Danaher Corporation
235.51
-0.36%
TMO Thermo Fisher Scientific Inc.
544.78
+0.60%
IQV IQVIA Holdings Inc.
228.09
+0.40%
ICLR ICON Public Limited Company
288.23
-1.23%
CRL Charles River Laboratories International, Inc.
226.78
-0.34%
ILMN Illumina, Inc.
117.43
+0.63%
A Agilent Technologies, Inc.
132.73
+0.22%